Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

Impact · against what's priced in

Johnson & Johnson's launch of the C2 Aero Fly catheter provides a productivity boost for hospitals by halving treatment time. This efficiency gain increases the potential for higher procedure volumes and strengthens the company's competitive moat against upcoming 2027 generic IVL entrants.

Scored by the NIS engine · methodology.

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

healthcare
cardiology
coronary artery disease

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

What matters in this story

IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

What matters in this story

IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites

Track these names every morning.

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Medtronic (MDT) Stock Dips While Market Gains: Key Facts

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

What matters in this story

Next reads from the same story arc

IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

What matters in this story

Next reads from the same story arc

IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites

Track these names every morning.

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Medtronic (MDT) Stock Dips While Market Gains: Key Facts